Study suggests link between fungi and ulcerative colitis

NewsGuard 100/100 Score

Cedars-Sinai researchers say their examination of the fungi in the intestines suggests an important link between these microbes and inflammatory diseases such as ulcerative colitis.

In the new study, published in the June 8 issue of Science, researchers at Cedars-Sinai's Inflammatory Bowel and Immunobiology Research Institute identified and characterized the large community of fungi inhabiting the large intestine in a model of the disease.

The digestive tract is home to a large number of micro-organisms. In fact, with an estimated 100 trillion bacteria residing in the gut, microbes outnumber human cells in the body. Some are necessary to aid in digesting food, producing necessary vitamins and suppressing the growth of harmful microbes. Others are harmful to the body, contributing to illnesses such as Crohn's disease, ulcerative colitis and obesity.

Modern DNA-sequencing technology has revolutionized the study of these microbes in the last decade, allowing the role of bacteria in disease to be understood more clearly, as is shown in the Cedars-Science research published in Science.

"It's long been recognized that fungi must also exist in the gut, but we're among the first to investigate what types, how many, and whether they're important in disease," said David Underhill, PhD, associate professor and director of the Graduate Program in Biomedical Science and Translational Medicine, who led the study. "We were truly stunned to see just how common fungi are, identifying more than 100 different types" and seeing linkages to digestive disorders.

An estimated 1.4 million Americans have Inflammatory Bowel Disease, or IBD, a chronic digestive disorder, and about 30,000 new cases are diagnosed annually. Ulcerative colitis, one of the most common types of IBD, causes inflammation and ulcers in the top layers of the lining of the large intestine. Common symptoms include abdominal pain, diarrhea, bleeding, fatigue, weight loss and loss of appetite. Ulcerative colitis patients can be at increased risk of developing colorectal cancer.

"This study takes us an important step closer to understanding how fungi contribute to disease, as well as significantly expanding our understanding of what types of fungi are living in our bodies," said Iliyan Iliev, PhD, a Cedars-Sinai research scientist and lead author on the study.

To determine fungi contribute to inflammatory disease, the study homed in on a protein called Dectin-1, produced by white blood cells and used by the immune system to detect and kill fungi. In an animal model of the disease, researchers found that the protein is important in protecting against inflammation caused by indigenous fungi. The finding has significant implications for human disease, as scientists at the Cedars-Sinai Medical Genetics Institute found a variant of the gene for Dectin-1 that is strongly associated with severe forms of ulcerative colitis.

Source: Cedars-Sinai

Comments

  1. Naax Tamblyn Naax Tamblyn Canada says:

    Holy Christ Jesus, i took you long enough, I've been telling my doctors this for a decade.  and they, of course, honour my observations with suggestions of mental health issues

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Investigating the efficacy and safety of existing drugs in patients with rare immune diseases